ArticleFrontiers in oncology2026
Preoperative C-reactive protein-to-albumin ratio as a prognostic marker of histopathological characteristics and survival outcomes following radical cystectomy.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Bladder cancer represents the second most common urological malignancy in Europe, and radical cystectomy is the cornerstone of treatment for muscle-invasive bladder cancer. Current research highlights the prognostic significance of markers reflecting inflammatory and nutritional status in oncology. As such, the aim of our study was to investigate the prognostic value of the C-reactive protein-to-albumin ratio (CAR) for histopathological characteristics and survival in bladder cancer patients who underwent radical cystectomy. Methods: A retrospective cohort study was conducted comprising 491 patients treated with radical cystectomy between 2017 and 2021, with postoperative survival follow up in June 2022. Results: Our results demonstrate that CAR is statistically significantly higher in patients with non-urothelial carcinoma compared to patients with urothelial carcinoma in the presence of lymphovascular invasion and cases of positive lymph nodes. CAR directly correlates with the pathological tumor stage. Multivariate analysis revealed that alongside histopathological tumor characteristics, CAR and age are independent predictors of patient survival following radical cystectomy. Discussion: Our study demonstrated a multifaceted association between CAR and the histopathological characteristics of bladder cancer following radical cystectomy. Furthermore, it was shown that CAR is an independent predictor of survival in these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.